CA2359650C - Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs - Google Patents

Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs Download PDF

Info

Publication number
CA2359650C
CA2359650C CA2359650A CA2359650A CA2359650C CA 2359650 C CA2359650 C CA 2359650C CA 2359650 A CA2359650 A CA 2359650A CA 2359650 A CA2359650 A CA 2359650A CA 2359650 C CA2359650 C CA 2359650C
Authority
CA
Canada
Prior art keywords
seq
polypeptide
amino acid
cys
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2359650A
Other languages
English (en)
Other versions
CA2359650A1 (fr
Inventor
Madhulika Baijal-Gupta
Jennifer Fraser
Seema Garde
Salam Kadhim
Chandra J. Panchal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kotinos Pharmaceuticals Inc
Original Assignee
Kotinos Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002321256A external-priority patent/CA2321256A1/fr
Priority claimed from CA002355334A external-priority patent/CA2355334A1/fr
Application filed by Kotinos Pharmaceuticals Inc filed Critical Kotinos Pharmaceuticals Inc
Priority to CA2359650A priority Critical patent/CA2359650C/fr
Publication of CA2359650A1 publication Critical patent/CA2359650A1/fr
Application granted granted Critical
Publication of CA2359650C publication Critical patent/CA2359650C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2359650A 2000-10-16 2001-10-15 Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs Expired - Fee Related CA2359650C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2359650A CA2359650C (fr) 2000-10-16 2001-10-15 Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA002321256A CA2321256A1 (fr) 2000-10-16 2000-10-16 Preparations pharmaceutiques, et methodes visant a inhiber la croissance de tumeurs
CA2,321,256 2000-10-16
CA2,355,334 2001-08-20
CA002355334A CA2355334A1 (fr) 2000-10-16 2001-08-20 Preparations pharmaceutiques et methodes visant a inhiber la croissance de tumeurs
CA2359650A CA2359650C (fr) 2000-10-16 2001-10-15 Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs

Publications (2)

Publication Number Publication Date
CA2359650A1 CA2359650A1 (fr) 2002-04-16
CA2359650C true CA2359650C (fr) 2013-02-12

Family

ID=27171367

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2359650A Expired - Fee Related CA2359650C (fr) 2000-10-16 2001-10-15 Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs

Country Status (1)

Country Link
CA (1) CA2359650C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2441695A1 (fr) * 2003-09-26 2005-03-26 Unknown Regulation de metalloproteinases matricielles par des membres de la famille de psp94

Also Published As

Publication number Publication date
CA2359650A1 (fr) 2002-04-16

Similar Documents

Publication Publication Date Title
US7655631B2 (en) Pharmaceutical preparations and methods for inhibiting tumors
AU2002213691A1 (en) Pharmaceutical preparations and methods for inhibiting tumors
JP2010154842A (ja) Ｅｇｆｒを標的にした新規抗がんキメラペプチド
EP3737399B1 (fr) Variants peptidiques atf5 et leurs utilisations
JP7030934B2 (ja) ナノ粒子製剤
JP2001520521A (ja) Ｖｐ２２タンパク質及びその使用
Kadkhodayan et al. Generation of GFP native protein for detection of its intracellular uptake by cell-penetrating peptides
CA2359650C (fr) Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs
AU697469B2 (en) Intracellular delivery of chemical agents to a specific cell type
AU2007249137A1 (en) Pharmaceutical preparations and methods for inhibiting tumors
ES2351783T3 (es) Preparaciones farmacéuticas y procedimientos para la inhibición de tumores.
KR102577502B1 (ko) 생체분자의 안정적 발현 및 전달을 위한 플라스미드 플랫폼
CA2361736A1 (fr) Psp94 : utilisation dans le traitement de l'hypercalcemie et de la metastase osseuse
CA2408387A1 (fr) Ligand pour ameliorer l'administration d'agents biologiques par voie orale et via le systeme nerveux central
WO2020230122A1 (fr) Peptides pour le traitement du cancer
KR20220163872A (ko) 화물분자 수송 도메인 rmmr1, 이의 변이체, 이를 포함하는 재조합 화물분자 및 이를 이용한 화물분자 수송 방법

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161017